Ascendis Pharma A/S is a biopharmaceutical company that focuses on developing innovative drug therapies for unmet medical needs. The company employs its proprietary TransCon technology platform to cre... Ascendis Pharma A/S is a biopharmaceutical company that focuses on developing innovative drug therapies for unmet medical needs. The company employs its proprietary TransCon technology platform to create therapeutic products that improve efficacy and therapeutic outcomes. Ascendis Pharma primarily targets endocrinology, aiming to treat conditions such as growth hormone deficiencies and hypoparathyroidism. The company's commitment to integrating advanced biotechnology through TransCon allows for sustained release and limited side effects, offering efficient and effective treatment options. Headquartered in Denmark, Ascendis Pharma plays a significant role in the biotech sector, driving innovation with a strong emphasis on developmental pipeline and collaborations designed to address complex diseases. With its growing presence and dedicated R&D initiatives, Ascendis continues to make critical contributions to the healthcare industry by delivering promising new therapies for rare conditions.
Pending data availability
EU Taxonomy Data missing for Ascendis Pharma
We haven’t collected EU Taxonomy data for Ascendis Pharma yet, or the company
hasn’t made it publicly available.